by Clinical Neuropsychologist Online | Friday, March 15, 2024 | Neuropsychology (general)
Volume 38, Issue 4, May 2024, Page 811-888. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 15, 2024 tandf: The Clinical Neuropsychologist: Table...
by Clinical Neuropsychologist Online | Friday, March 15, 2024 | Neuroscience
Nature Neuroscience, Published online: 15 March 2024; doi:10.1038/s41593-024-01588-5Cortical excitatory neurons are narrowly tuned to sensory inputs, but the tuning of interneurons is perceived as broad and irregular. Duszkiewicz et al. demonstrate that interneuron...
by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia
Abstract INTRODUCTION Dementia risk may be elevated in socioeconomically disadvantaged neighborhoods. Reasons for this remain unclear, and this elevation has yet to be shown at a national population level. METHODS We tested whether dementia was more prevalent in...
by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 14, 2024 Wiley: Alzheimer’s & Dementia: Table...
by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia
Abstract Prior authorization criteria for Federal Drug Administration (FDA) approved immunotherapeutics, among the class of anti-amyloid monoclonal antibodies (mAbs), established by state drug formulary committees, are tailored for adults with late-onset...
